LOS ANGELES (Jan. 23, 2013) – With the rising awareness of the so-called “superbugs,” bacteria that are resistant to most known antibiotics, three infectious disease experts writing in the Jan. 24 edition of the New England Journal of Medicine called for novel approaches based on a “reconceptualization of the nature of resistance, disease and prevention.”

LOS ANGELES (Jan. 16, 2013) – In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain.

LA BioMed was recently accredited for various research programs. Dr. Matthew Budoff is leading one such study on testosterone and its effect on the hearts of patients. (Robert Casillas / Staff Photographer)
 
Carlos Portillo visited LA BioMed this week, just as he has done regularly for two years, for a round of blood tests and probing questions.

Portillo, who is HIV-positive, is participating in one of the research center’s 200 ongoing clinical trials, testing a combination of medications so doctors can determine what pairings work best.

Bisphenol A, better known as BPA, was recently banned in baby bottles but the FDA stopped short of completely nixing the chemical.

A common chemical found in the lining of water bottles, aluminum cans and other food packaging may put children at risk of developing kidney and heart disease, according to a study from the NYU School of Medicine.

Researchers analyzed data on more than 700 children, focusing on the amount of Bisphenol A, better known as BPA, in their urine.